Brief: Kodiak Sciences Inc - Still Evaluating A Variety Of Future Options For Tarcocimab Program
Kodiak Sciences Inc KOD.O :
* KODIAK SCIENCES INC - STILL EVALUATING A VARIETY OF FUTURE
OPTIONS FOR TARCOCIMAB PROGRAM
* KODIAK SCIENCES INC - KODIAK WILL BE ADVANCING KSI-501
CLINICAL
PROGRAM
* KODIAK SCIENCES INC - PLANNING TO EXPLORE DEVELOPMENT OF
KSI-501
IN ITS TWO THERAPEUTIC FORMS
Source text for Eikon: ID:
Further company coverage: KOD.O
Recent news on Kodiak Sciences
See all newsBrief: Kodiak Sciences Inc. Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike
Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX